Exhibit 10.36
Conformed Copy
$250,000,000
BLACKROCK, INC.
2.625% Convertible Debentures Due
2035
PURCHASE AGREEMENT
February 16, 2005
Exhibit 10.36
SCHEDULE A
The following table sets forth the
hypothetical stock price and the number of Additional Shares to be
issuable per $1,000 principal amount of Debentures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Price
|
|
Effective Date
|
|
$77.58
|
|
$85.00
|
|
$90.00
|
|
$95.00
|
|
$100.00
|
|
$105.00
|
|
$110.00
|
|
$115.00
|
|
$120.00
|
|
$130.00
|
|
150.00
|
|
$175.00
|
|
$200.00
|
|
$250.00
|
|
$300.00
|
|
February 23, 2005
|
|
3.16
|
|
2.45
|
|
2.08
|
|
1.77
|
|
1.52
|
|
1.31
|
|
1.13
|
|
0.99
|
|
0.87
|
|
0.68
|
|
0.46
|
|
0.31
|
|
0.23
|
|
0.15
|
|
0.10
|
|
February 15, 2006
|
|
3.05
|
|
2.32
|
|
1.93
|
|
1.62
|
|
1.36
|
|
1.16
|
|
0.99
|
|
0.85
|
|
0.73
|
|
0.56
|
|
0.36
|
|
0.24
|
|
0.18
|
|
0.12
|
|
0.08
|
|
February 15, 2007
|
|
2.99
|
|
2.21
|
|
1.81
|
|
1.48
|
|
1.22
|
|
1.01
|
|
0.84
|
|
0.70
|
|
0.59
|
|
0.44
|
|
0.27
|
|
0.18
|
|
0.14
|
|
0.09
|
|
0.06
|
|
February 15, 2008
|
|
2.95
|
|
2.10
|
|
1.66
|
|
1.32
|
|
1.04
|
|
0.83
|
|
0.66
|
|
0.53
|
|
0.43
|
|
0.30
|
|
0.17
|
|
0.12
|
|
0.09
|
|
0.06
|
|
0.04
|
|
February 15, 2009
|
|
2.97
|
|
2.00
|
|
1.50
|
|
1.10
|
|
0.80
|
|
0.58
|
|
0.42
|
|
0.30
|
|
0.22
|
|
0.14
|
|
0.08
|
|
0.06
|
|
0.05
|
|
0.03
|
|
0.02
|
|
February 15, 2010
|
|
3.16
|
|
2.04
|
|
1.38
|
|
0.80
|
|
0.27
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
Exhibit 10.36
SCHEDULE B
BLACKROCK, INC.
2.625% Convertible Debentures Due
2035
No.
|
|
|
|
|
|
|
|
|
Date
|
|
Principal Amount
|
|
Notation Explaining
Principal Amount
Recorded
|
|
Authorized Signature
of Trustee or
Custodian
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 16, 2005
Morgan Stanley & Co. Incorporated
Citigroup Global Markets Inc.
Merrill Lynch, Pierce, Fenner & Smith
Incorporated
UBS Securities LLC
|
c/o
|
Morgan Stanley
& Co. Incorporated
|
Dear Sirs and Mesdames:
BlackRock, Inc., a Delaware
corporation (the “ Company ”), proposes to issue
and sell to the several purchasers named in Schedule I hereto (the
“ Initial Purchasers ”)
$250,000,000 aggregate principal
amount of its 2.625% Convertible Debentures Due 2035 (the “
Securities ”) to be issued pursuant to the provisions
of an Indenture to be dated as of February 23, 2005 (the “
Indenture ”) between the Company and JPMorgan Chase
Bank, N.A., as Trustee (the “ Trustee ”). The
Securities will be convertible into shares of the Company’s
Class A common stock, $0.01 par value (the “ Underlying
Securities ”).
The Securities and the Underlying
Securities will be offered without being registered under the
Securities Act of 1933, as amended (the “ Securities
Act ”), to qualified institutional buyers in compliance
with the exemption from registration provided by Rule 144A under
the Securities Act.
The Initial Purchasers and their
direct and indirect transferees will be entitled to the benefits of
a Registration Rights Agreement dated the Closing Date (as defined
herein) between the Company and the Initial Purchasers (the “
Registration Rights Agreement ”).
In connection with the sale of the
Securities, the Company has prepared a preliminary offering
memorandum (the “ Preliminary Memorandum ”) and
will prepare a final offering memorandum (the “ Final
Memorandum ” and, with the Preliminary Memorandum, each a
“ Memorandum ”) including or incorporating by
reference a description of the terms of the Securities and the
Underlying Securities, the terms of the offering and a description
of the Company. As used herein, the term “Memorandum”
shall include in each case the documents incorporated by reference
therein. The terms “ supplement ”, “
amendment ” and “ amend ” as used
herein with respect to a Memorandum shall include all documents
deemed to be incorporated by reference in the Preliminary
Memorandum or Final Memorandum that are filed subsequent to the
date of such Memorandum with the Securities and Exchange Commission
(the
“ Commission ”) pursuant to
the Securities Exchange Act of 1934, as amended (the “
Exchange Act ”).
1. Representations and
Warranties . The Company represents and warrants to, and agrees
with, you that:
(a) (i) Each document, if any, filed
or to be filed pursuant to the Exchange Act and incorporated by
reference in either Memorandum complied or will comply when so
filed in all material respects with the Exchange Act and the
applicable rules and regulations of the Commission thereunder and
(ii) the Preliminary Memorandum does not contain and the Final
Memorandum, in the form used by the Initial Purchasers to confirm
sales and on the Closing Date (as defined in Section 4), will not
contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading, except that the representations and warranties set
forth in this paragraph do not apply to statements or omissions in
either Memorandum based upon information relating to any Initial
Purchaser furnished to the Company in writing by such Initial
Purchaser through you expressly for use therein.
(b) The Company has been duly
incorporated, is validly existing as a corporation in good standing
under the laws of the Delaware, has the corporate power and
authority to own or lease its property and to conduct its business
as described in each Memorandum and is duly qualified to transact
business and is in good standing in each jurisdiction in which the
conduct of its business or its ownership or leasing of property
requires such qualification, except to the extent that the failure
to be so qualified or be in good standing would not have a material
adverse effect on the Company and its subsidiaries, taken as a
whole.
(c) Each subsidiary of the Company
listed on Schedule II (the “subsidiaries”) hereto has
been duly organized, is validly existing as a corporation or
limited liability company, as the case may be, in good standing
under the laws of the jurisdiction of its formation, has the
corporate or limited liability company power and authority, as the
case may be, to own or lease its property and to conduct its
business as described in each Memorandum and is duly qualified to
transact business and is in good standing in each jurisdiction in
which the conduct of its business or its ownership or leasing of
property requires such qualification, except to the extent that the
failure to be so qualified or be in good standing would not have a
material adverse effect on the Company and its subsidiaries, taken
as a whole; all of the issued shares of capital stock or membership
interests, as the case may be, of each subsidiary of the Company
have been duly and validly authorized and issued and are owned
directly or indirectly by the Company, free and clear of all
liens,
2
encumbrances, equities or claims and
the issued shares of capital stock are fully paid and
non-assessable.
(d) This Agreement has been duly
authorized, executed and delivered by the Company.
(e) The authorized capital stock of
the Company conforms as to legal matters to the description thereof
contained in the Final Memorandum.
(f) The shares of common stock
outstanding prior to the issuance of the Securities have been duly
authorized and validly issued and are fully paid and
non-assessable.
(g) The Securities have been duly
authorized by the Company and, when executed and authenticated in
accordance with the provisions of the Indenture and delivered to
and paid for by the Initial Purchasers in accordance with the terms
of this Agreement, will be valid and binding obligations of the
Company, enforceable in accordance with their terms, subject to
applicable bankruptcy, insolvency or similar laws affecting
creditors’ rights generally and general principles of equity,
and will be entitled to the benefits of the Indenture pursuant to
which such Securities are to be issued and the Registration Rights
Agreement.
(h) The Underlying Securities
issuable upon conversion of the Securities have been duly
authorized and reserved and, when issued upon conversion of the
Securities in accordance with the terms of the Securities, will be
validly issued, fully paid and non–assessable, and the
issuance of the Underlying Securities will not be subject to any
preemptive or similar rights.
(i) Each of the Indenture and the
Registration Rights Agreement has been duly authorized, executed
and delivered by, and is a valid and binding agreement of, the
Company, enforceable in accordance with its terms, subject to
applicable bankruptcy, insolvency or similar laws affecting
creditors’ rights generally and general principles of equity
and except as rights to indemnification and contribution under the
Registration Rights Agreement may be limited under applicable
law.
(j) The execution and delivery by
the Company of, and the performance by the Company of its
obligations under, this Agreement, the Indenture, the Registration
Rights Agreement and the Securities will not contravene any
provision of applicable law, statute, rule, regulation, or the
certificate of incorporation or by-laws of the Company or any
agreement or other instrument binding upon the Company or any of
its subsidiaries that is material to the Company and its
subsidiaries, taken as a whole, any
3
judgment, order or decree of any
governmental body, agency, court or self–regulatory
organization having jurisdiction over the Company or any
subsidiary, and no filing with or consent, approval, authorization,
license or order of, or qualification or registration with, any
governmental body, agency or self-regulatory organization is
required for the performance by the Company of its obligations
under this Agreement, the Indenture, the Registration Rights
Agreement or the Securities, except such as may be required by the
securities or Blue Sky laws of the various states or other
jurisdictions in connection with the offer and sale of the
Securities and by Federal and state securities laws with respect to
the Company’s obligations under the Registration Rights
Agreement.
(k) There has not occurred any
material adverse change, or any development involving a prospective
material adverse change, in the financial condition, or in the
earnings, business or operations of the Company and its
subsidiaries, taken as a whole, from that set forth in the
Preliminary Memorandum provided to prospective purchasers of the
Securities.
(l) There are no legal or
governmental proceedings, actions, suits, inquiries or
investigations pending or threatened to which the Company or any of
its subsidiaries is a party or to which any of the properties of
the Company or any of its subsidiaries is subject other than (i)
proceedings accurately described in all material respects in each
Memorandum and (ii) proceedings that would not have a material
adverse effect on the Company and its subsidiaries, taken as a
whole, or on the power or ability of the Company to perform its
obligations under this Agreement, the Indenture, the Registration
Rights Agreement or the Securities or to consummate the
transactions contemplated by the Final Memorandum.
(m) The Company and its subsidiaries
are in compliance with any and all applicable foreign, federal,
state and local laws and regulations relating to the protection of
human health and safety, the environment or hazardous or toxic
substances or wastes, pollutants or contaminants except where such
non-compliance would not, singly or in the aggregate, have a
material adverse effect on the Company and its subsidiaries, taken
as a whole.
(n) The Company is not, and solely
after giving effect to the offering and sale of the Securities and
the application of the proceeds thereof as described in the Final
Memorandum will not be, required to register as an
“investment company” as such term is defined in the
Investment Company Act of 1940, as amended (the “ 1940
Act ”).
4
(o) Neither the Company nor any
affiliate (as defined in Rule 501(b) of Regulation D under the
Securities Act, an “ Affiliate ”) of the Company
has directly, or through any agent, (i) sold, offered for sale,
solicited offers to buy or otherwise negotiated in respect of, any
security (as defined in the Securities Act) which is or will be
integrated with the sale of the Securities in a manner that would
require the registration under the Securities Act of the Securities
or (ii) offered, solicited offers to buy or sold the Securities by
any form of general solicitation or general advertising (as those
terms are used in Regulation D under the Securities Act) or in any
manner involving a public offering within the meaning of Section
4(2) of the Securities Act.
(p) It is not necessary in
connection with the offer, sale and delivery of the Securities to
the Initial Purchasers in the manner contemplated by this Agreement
to register the Securities under the Securities Act or to qualify
the Indenture under the Trust Indenture Act of 1939, as
amended.
(q) The Securities satisfy the
requirements set forth in Rule 144A(d)(3) under the Securities
Act.
(r) Each of the Company and its
subsidiaries owns or possesses, or can acquire on reasonable terms,
all adequate patents, patent rights, licenses, inventions,
copyrights, know how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information,
systems or procedures), trademarks, service marks and trade names
necessary to carry on the business now operated by them, and
neither the Company nor any of its subsidiaries has received any
notice of infringement of or conflict with asserted rights of
others with respect to any of the foregoing which, singly or in the
aggregate, if the subject of an unfavorable decision, ruling or
finding, would have a material adverse affect on the Company and
its subsidiaries, taken as a whole.
(s) The Company and each of its
subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as
are prudent and customary in the businesses in which they are
engaged; neither the Company nor any of its subsidiaries has been
refused any insurance coverage sought or applied for; and neither
the company nor any of its subsidiaries has any reason to believe
that it will not be able to renew its existing insurance coverage
as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business
at a cost that would not have a material adverse affect on the
Company and its subsidiaries, taken as a whole, except as described
in the Memorandum.
5
(t) The Company and its subsidiaries
possess all certificates, authorizations, licenses, approvals,
consents, permits and other authorizations issued by the
appropriate federal, state or foreign regulatory authorities
necessary to conduct their respective businesses, and neither the
Company nor any of its subsidiaries has received any notice of
proceedings relating to the revocation or modification of any such
certificate, authorization, licenses, approval, consent, permit or
other authorization which, singly or in the aggregate, if the
subject of an unfavorable decision, ruling or finding, would have a
material adverse affect on the Company and its subsidiaries, taken
as a whole, except as described in the Memorandum.
(u) The Company and each of its
subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (i) transactions
are executed in accordance with management’s general or
specific authorizations; (ii) transactions are recorded as
necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to
maintain asset accountability; (iii) access to assets is permitted
only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any
differences.
(v) The Company has established and
maintained disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) that are adequate and
effective and designed to ensure that material information relating
to the Company, including its consolidated subsidiaries, is made
known to its chief executive officer and chief financial officer by
others within those entities.
(w) The consolidated financial
statements incorporated by reference in the Memorandum, together
with related schedules and notes, present fairly in all material
respects the financial position of the Company and its consolidated
subsidiaries at the dates indicated and the statement of operations
and stockholders’ equity and cash flows of the Company and
its consolidated subsidiaries for the periods specified, said
financials have been prepared in accordance with generally accepted
accounting principles (“ GAAP ”) applied on a
consistent basis throughout the periods involved, except as
disclosed therein; and the other financial information and data set
forth in the Memorandum present fairly, in all material respects,
the information shown therein and have been compiled on a basis
consistent with that of the audited financial statements included
or incorporated by reference in the Memorandum.
(x) The Company and its subsidiaries
have good and marketable title in fee simple to all real property
and good and marketable
6
title to all personal property owned
by them which is material to the business of the Company and its
subsidiaries, in each case free and clear of all liens,
encumbrances and defects except such as are described in the
Memorandum or such as do not materially affect the value of such
property and do not interfere with the use made and proposed to be
made of such property by the Company and its subsidiaries; and any
real property and buildings held under lease by the Company and its
subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material and do
not interfere with the use made and proposed to be made of such
property and buildings by the Company and its subsidiaries, in each
case except as described in the Memorandum.
(y) Each of BlackRock Advisors,
Inc., BlackRock Institutional Management Corporation, BlackRock
Financial Management, Inc., BlackRock (Japan), Inc., BlackRock
Capital Management, Inc., BlackRock HPB Management, LLC, State
Street Research Management Company, BlackRock Realty Advisors, Inc.
and BlackRock International Ltd. (together, the “
Investment Adviser Subsidiaries ”) is duly registered
as an investment adviser under the Investment Advisers Act of 1940,
as amended (the “ Advisers Act ”) and none of
the Investment Adviser Subsidiaries is prohibited by any provision
of the Advisers Act or the 1940 Act, or the respective rules and
regulations thereunder, from acting as an investment adviser. The
Investment Adviser Subsidiaries are the only direct or indirect
subsidiaries of the Company required to be registered as investment
advisers under the Advisers Act. Each of the Investment Adviser
Subsidiaries is duly registered, licensed or qualified as an
investment adviser in each jurisdiction where the conduct of its
business requires such registration and is in compliance with all
federal, state and foreign laws requiring any such registration,
licensing or qualification or is subject to no material liability
or disability by reason of the failure to be so registered,
licensed or qualified in any such jurisdiction or to be in such
compliance. None of the Company or its other direct or indirect
subsidiaries is required to be registered, licensed or qualified as
an investment adviser under the laws requiring any such
registration, licensing or qualification in any jurisdiction in
which it or such other subsidiaries conduct business or is subject
to material liability or disability by reason of the failure to be
so registered, licensed or qualified.
(z) Each of BlackRock Investments,
Inc. and State Street Research Investment Services (the “
Broker Dealer Subsidiaries ”) is duly registered,
licensed or qualified as a broker-dealer under the Exchange Act,
and under the securities laws of each jurisdiction where the
conduct of its business requires such registration and is in
compliance with all federal, state and foreign laws requiring such
registration, licensing or
7
qualification or is subject to no
material liability or disability by reason of the failure to be so
registered, licensed or qualified in any such jurisdiction or to be
in such compliance. Each of the Broker Dealer Subsidiaries is a
member in good standing of NASD and each other self-regulatory
organization where the conduct of its business requires such
membership. Neither the Company nor any of the Company’s
other direct or indirect subsidiaries is required to be registered,
licensed or qualified as a broker-dealer under the laws requiring
any such registration, licensing or qualification in any
jurisdiction in which it or such other subsidiaries conduct
business or is subject to any material liability or disability by
reason of the failure to be so registered, licensed or qualified
except where the failure to be so registered, licensed or qualified
would not have a material adverse affect on the Company and its
subsidiaries, taken as a whole.
(aa) Each of the Investment Adviser
Subsidiaries and the Broker Dealer Subsidiaries is, has been and
will upon consummation of the transactions contemplated herein be,
in compliance with, and each such entity has received no notice of
any kind of any violation of, (A) all laws, regulations, ordinances
and rules (including those of any non-governmental self-regulatory
agencies) applicable to it or its operations relating to investment
advisory or broker-dealer activities, as the case may be, and (B)
all other laws, regulations, ordinances and rules applicable to it
and its operations, except, in either case, where any failure to
comply with any such law, regulation, ordinance or rule would not
have, individually or in the aggregate, a material adverse effect
on the Company and its subsidiaries taken as a whole.
(bb) Each entity for which the
Investment Adviser Subsidiaries acts as investment adviser and, to
the best knowledge of the Investment Adviser Subsidiaries, each
entity for which the Investment Adviser Subsidiaries acts as
sub-adviser and, in each case, which is required to be registered
with the Commission as an investment company under the 1940 Act (a
“ Fund ”) is, and upon consummation of the
transactions contemplated